Stock Earnings KPTI (Karyopharm Therapeutics Inc) may reap gains as insiders became active recently Karyopharm Therapeutics Inc’s filing revealed that its President and CEO Paulson Richard A. unloaded Company’s shares for reported $1680.0 on